20537689

Source:http://linkedlifedata.com/resource/pubmed/id/20537689

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005516, umls-concept:C0085862, umls-concept:C0205556, umls-concept:C0242792, umls-concept:C0677886, umls-concept:C0681842, umls-concept:C1299583, umls-concept:C1366550, umls-concept:C1521871, umls-concept:C1549571, umls-concept:C1608386
pubmed:issue	2
pubmed:dateCreated	2010-7-8
pubmed:abstractText	The purpose of this study was to identify genes that predict progression-free survival (PFS) in advanced epithelial ovarian cancer (aEOC) receiving standard therapy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/GNAS protein, human, http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Protein alpha..., http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1095-6859
pubmed:author	pubmed-author:AokiDaisukeD, pubmed-author:AraoTokuzoT, pubmed-author:HirasawaAkiraA, pubmed-author:KataokaFumioF, pubmed-author:NishimuraSadakoS, pubmed-author:NishioKazutoK, pubmed-author:NomuraHiroyukiH, pubmed-author:TakanoMasashiM, pubmed-author:TominagaEi-ichiroE, pubmed-author:TsudaHiroshiH
pubmed:copyrightInfo	Copyright (c) 2010 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	118
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	160-6
pubmed:meshHeading	pubmed-meshheading:20537689-Adult, pubmed-meshheading:20537689-Aged, pubmed-meshheading:20537689-Aged, 80 and over, pubmed-meshheading:20537689-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20537689-Carboplatin, pubmed-meshheading:20537689-Chemotherapy, Adjuvant, pubmed-meshheading:20537689-Disease-Free Survival, pubmed-meshheading:20537689-Epithelial Cells, pubmed-meshheading:20537689-Female, pubmed-meshheading:20537689-GTP-Binding Protein alpha Subunits, Gs, pubmed-meshheading:20537689-Gene Amplification, pubmed-meshheading:20537689-Humans, pubmed-meshheading:20537689-Middle Aged, pubmed-meshheading:20537689-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:20537689-Ovarian Neoplasms, pubmed-meshheading:20537689-Paclitaxel, pubmed-meshheading:20537689-Predictive Value of Tests, pubmed-meshheading:20537689-RNA, Messenger, pubmed-meshheading:20537689-RNA, Neoplasm, pubmed-meshheading:20537689-Reproducibility of Results, pubmed-meshheading:20537689-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20537689-Tumor Markers, Biological
pubmed:year	2010
pubmed:articleTitle	Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer.
pubmed:affiliation	Department of Obstetrics and Gynecology, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, Tokyo, Japan.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't